Charles River Laboratories (CRL) Tops Q2 EPS by 2c; Adds $10M to Buybacks

July 31, 2013 4:26 PM

Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.73, $0.02 better than the analyst estimate of $0.71. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found